--- title: "Navigating Misalignment Exception Management Under DSCSA: Challenges and Solutions" description: Managing DSCSA misalignment exceptions is critical for compliance. Learn key challenges, causes, and solutions to streamline pharmaceutical traceability. image: https://blog.cosmotrace.com/hubfs/US%20DSCSA%20-%20Exception%20Management%20Feb%2028%202025%20-%20Social%20Post.jpg --- +44 203 097 1597 [info@cosmotrace.com](mailto:info@cosmotrace.com) - - - - [![Cosmotrace](https://blog.cosmotrace.com/hs-fs/hubfs/raw_assets/public/CosmoTrace_Oct2021/images/cosmotrace-2.png?width=630&height=209&name=cosmotrace-2.png "Cosmotrace")](https://www.cosmotrace.com/) - [Home](https://www.cosmotrace.com/) - [About Us](https://www.cosmotrace.com/about-us/) - [Careers](https://www.cosmotrace.com/pages/careers/) - [Services](https://www.cosmotrace.com/our-services/) - Compliance Focused - [Misalignment Exceptions Management (US DSCSA)](https://www.cosmotrace.com/our-services/misalignment-exceptions-management-us-dscsa/) - [EU Alert Management](https://www.cosmotrace.com/our-services/eu-alert-management/) - [Middle East Serialization Consulting](https://www.cosmotrace.com/our-services/middle-east-serialization-consulting/) - [China Reporting Services](https://www.cosmotrace.com/our-services/china-reporting-services/) - Business Operations Focused - [Master Data Management](https://www.cosmotrace.com/our-services/master-data-management/) - [Trade Partner Onboarding](https://www.cosmotrace.com/our-services/trade-partner-onboarding/) - [Level 4 System Validation](https://www.cosmotrace.com/our-services/level-4-system-validation/) - [Serialization System Health Check](https://www.cosmotrace.com/our-services/serialization-system-health-check/) - Business Processes Outsourcing - [Managed Services CoE](https://www.cosmotrace.com/our-services/managed-services-coe/) - [US DSCSA Ti Digitization](https://www.cosmotrace.com/our-services/us-dscsa-ti-digitization/) - [Our Solutions](https://www.cosmotrace.com/solutions/) - [Traceware](https://www.cosmotrace.com/solutions/traceware/) - [nTrack](https://www.cosmotrace.com/solutions/ntrack/) - [Clients](https://www.cosmotrace.com/clients/) - [Blog](https://www.cosmotrace.com/blog/) - [Serialization](https://www.cosmotrace.com/blog/serialization) - [Digital](https://www.cosmotrace.com/blog/digital) - [News](https://www.cosmotrace.com/blog/news/) - [Contact](https://www.cosmotrace.com/contact-us/) - - - - - [Home](https://www.cosmotrace.com/) - [About Us](https://www.cosmotrace.com/about-us/) - [Careers](https://www.cosmotrace.com/pages/careers/) - [Services](https://www.cosmotrace.com/our-services/) - Compliance Focused - [Misalignment Exceptions Management (US DSCSA)](https://www.cosmotrace.com/our-services/misalignment-exceptions-management-us-dscsa/) - [EU Alert Management](https://www.cosmotrace.com/our-services/eu-alert-management/) - [Middle East Serialization Consulting](https://www.cosmotrace.com/our-services/middle-east-serialization-consulting/) - [China Reporting Services](https://www.cosmotrace.com/our-services/china-reporting-services/) - Business Operations Focused - [Master Data Management](https://www.cosmotrace.com/our-services/master-data-management/) - [Trade Partner Onboarding](https://www.cosmotrace.com/our-services/trade-partner-onboarding/) - [Level 4 System Validation](https://www.cosmotrace.com/our-services/level-4-system-validation/) - [Serialization System Health Check](https://www.cosmotrace.com/our-services/serialization-system-health-check/) - Business Processes Outsourcing - [Managed Services CoE](https://www.cosmotrace.com/our-services/managed-services-coe/) - [US DSCSA Ti Digitization](https://www.cosmotrace.com/our-services/us-dscsa-ti-digitization/) - [Our Solutions](https://www.cosmotrace.com/solutions/) - [Traceware](https://www.cosmotrace.com/solutions/traceware/) - [nTrack](https://www.cosmotrace.com/solutions/ntrack/) - [Clients](https://www.cosmotrace.com/clients/) - [Blog](https://www.cosmotrace.com/blog/) - [Serialization](https://www.cosmotrace.com/blog/serialization) - [Digital](https://www.cosmotrace.com/blog/digital) - [News](https://www.cosmotrace.com/blog/news/) - [Contact](https://www.cosmotrace.com/contact-us/) - - - - # Navigating Misalignment Exception Management Under DSCSA: Challenges and Solutions Feb 28, 2025 | ![Navigating Misalignment Exception Management Under DSCSA: Challenges and Solutions](https://blog.cosmotrace.com/hubfs/US%20DSCSA%20-%20Exception%20Management%20Feb%2028%202025%20-%20Social%20Post.jpg) The **U.S. Drug Supply Chain Security Act (DSCSA)** aims to enhance pharmaceutical traceability, but misalignment exceptions remain a persistent challenge. Exception management, especially for manufacturers is a critical aspect of compliance, yet many in the industry struggle with **data discrepancies, reporting delays, and system interoperability issues**. This blog explores the **current state of the industry, the causes of exceptions, who is responsible, and the ideal approach for resolution**. # **Understanding Misalignment Exceptions in DSCSA** Misalignment exceptions occur when there are **discrepancies in serialized data across trading partners** in the supply chain. These discrepancies can stem from missing, incorrect, or delayed data exchanges between **manufacturers, wholesalers, and dispensers**. If unresolved, exceptions can **disrupt product movement, create compliance risks, and delay patient access to critical medications**. ### **Who Is to Blame for DSCSA Exceptions?** No single stakeholder is entirely at fault, but exceptions typically arise from: 1. **Manufacturers** – Errors in serial number aggregation, missing Electronic Product Code Information Services (EPCIS) data, or incorrect product identifiers. 2. **Wholesalers/Distributors** – Data processing delays, master data mismatches, or failure to reconcile product data with physical inventory. 3. **Dispensers/Pharmacies** – Difficulty verifying serialized data due to outdated systems or incomplete data transmissions. 4. **Solution Providers** – Integration gaps between traceability platforms and trading partner systems, leading to data inconsistencies. ### **Why Are DSCSA Exceptions Reported Late?** The **delay in reporting and resolving exceptions** is one of the biggest hurdles to compliance. Some key reasons include: - **Lack of real-time exception detection** – Many stakeholders rely on batch processing rather than immediate issue identification. - **Unclear ownership of resolution** – Without well-defined responsibilities, companies may hesitate to take corrective action. - **Interoperability issues** – Trading partners using different systems may face delays in data synchronization. - **Manual investigation efforts** – Exceptions often require **human intervention**, slowing down the resolution process. ### **When and How Are DSCSA Exceptions Detected?** Misalignment exceptions can surface at different points in the supply chain: - **Manufacturers** – During packaging and serialization, errors like duplicate serial numbers or aggregation mistakes may occur. - **Distributors** – Issues arise when receiving serialized shipments that do not match the expected EPCIS data. - **Dispensers** – Verification failures at the point of dispensing can flag misalignments. - **Regulatory Audits** – The **FDA or state boards of pharmacy** may identify discrepancies during inspections. ### **The Ideal Approach to DSCSA Exception Management** To streamline exception management, the industry must focus on three key areas: #### **Stronger Stakeholder Collaboration** - Clearer **Standard Operating Procedures (SOPs)** for handling exceptions. - Well-defined **roles and responsibilities** to ensure quick resolution. - **Data-sharing agreements** to improve communication between trading partners. #### **Enhanced Technical Support & System Interoperability** - More **real-time EPCIS data transmission** to reduce delays. - Adoption of **GS1 standards** for better data consistency. - **Automation** for faster issue detection and resolution. #### **Conclusion** Misalignment exceptions under DSCSA pose a **significant challenge** for manufacturers and the broader pharmaceutical supply chain. However, **no single entity is solely responsible**. Resolution requires **better collaboration, robust technology, and regulatory alignment**. By implementing proactive exception management strategies, the industry can **reduce compliance risks, improve data accuracy, and ultimately enhance patient safety**. Would you like to explore specific best practices for your organization’s exception management strategy? Let’s discuss.   [![Contact us for a free consultation](https://no-cache.hubspot.com/cta/default/6755855/e65d3a53-10e4-4793-9101-dcab70f292f8.png)](https://cta-redirect.hubspot.com/cta/redirect/6755855/e65d3a53-10e4-4793-9101-dcab70f292f8)   #### Search #### Recent Posts - [Egypt’s Pharmaceutical Track and Trace - From 2019 Pilot to 2025 Nationwide Mandate](https://blog.cosmotrace.com/serialization/egypt-pharma-traceability-2025-mandate) - [Algeria’s 2027 Pharmaceutical Serialization & Aggregation](https://blog.cosmotrace.com/serialization/algeria-2027-pharmaceutical-serialization-aggregation) - [Serialization and Traceability in the Middle East: Navigating a Complex Compliance Landscape](https://blog.cosmotrace.com/serialization/middle-east-serialization-traceability-compliance) - [Sri Lanka Extends Barcode Grace Period for Medicines: What MAHs Need to Know](https://blog.cosmotrace.com/serialization/sri-lanka-barcode-grace-period-extension) - [DSCSA Enforcement Timeline: What Trading Partners Need to Know in 2025](https://blog.cosmotrace.com/serialization/dscsa-enforcement-timeline-2025) - - - - © 2020 CosmoTrace - part of ZeeInx Group